Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Dexmedetomidine Combined With Ropivacaine for Postoperative Continuous Femoral Nerve Block on Postoperative Delirium and Long-term Oucomes in Elderly Patients After Single Knee Arthroplasty

NCT03629483 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT03629483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03629483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Dexmedetomidine Combined With Ropivacaine for Postoperative Continuous Femoral Nerve Block on Postoperative Delirium and Long-term Oucomes in Elderly Patients After Single Knee Arthroplasty
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Terminated
Start date
December 10, 2018
Completion date
December 14, 2018
Enrollment
3 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dexmedetomidine, elderly, knee arthroplasty, long-term outcome, nerve block, postoperative delirium